M&T Bank’s Kite Pharma, Inc. KITE Stock Holding History

M&T Bank’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,028	Closed	-$1.26M	–	1713
2017 Q3	$1.26M	Buy	7,028 +60	+0.9%	+$8.36K	0.01%	677
2017 Q2	$722K	Hold	6,968	–	–	﹤0.01%	856
2017 Q1	$547K	Buy	+6,968	New	+$431K	﹤0.01%	963
2015 Q3	–	Sell	-10,875	Closed	-$663K	–	2142
2015 Q2	$663K	Buy	10,875 +4,764	+78%	+$272K	﹤0.01%	1066
2015 Q1	$353K	Buy	+6,111	New	+$410K	﹤0.01%	1354

M&T Bank's KITE Position: Q4 2017 in Review

M&T Bank sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 7,028 shares — an estimated $1.26M sold.

M&T Bank first reported a position in KITE in Q1 2015 and held it in 5 quarters. The position peaked at $1.26M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

M&T Bank reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
M&T Bank sold 7,028 Kite Pharma, Inc. shares in Q4 2017, an estimated $1.26M.
M&T Bank first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 5 quarters.
M&T Bank's Kite Pharma, Inc. position peaked at $1.26M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on M&T Bank's 13F filing for Q4 2017, filed 6 Feb 2018.